Platelet transfusions in advanced hematological malignancies: a position paper.
Treatment of patients with advanced-stage hematological malignancies (HM) includes frequent transfusions. Given present limited hospital budgets, administrative pressure is increasing on hematology services to limit the cost of these transfusions. An expert multidisciplinary panel involved in hematology formed a working party to draw up a series of proposals, including definitions of advanced stage disease and the indications for platelet transfusion. Their proposals included: (a) Platelet transfusions are indicated for the treatment of bleeding caused by low platelet counts; (b) Patients should receive full information, including the basic criteria for platelet transfusion; (c) Doctors should be trained to assess whether or not platelet transfusions are urgently required; and (d) The practice of home transfusions should be encouraged.
Lassauniere
J M
JM
Center for Palliative Care, Hotel-Dieu, Paris, France.
Bertolino
M
M
Hunault
M
M
Zittoun
R
R
Verspieren
P
P
Moh-Klaren
J
J
Jaulmes
D
D
Colombat
P
P
D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000628:therapy*; D003657:Decision Making; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D010297:Paris; D017713:Platelet Transfusion / Q000191:economics; D011788:Quality of Life